Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales57 99649 41448 51849 17450 83552 528
EBITDA19 36715 26014 31115 07415 91516 773
Operating profit (EBIT)14 61613 79012 98711 96212 91913 638
Pre-Tax Profit (EBT)11 9218 1347 8179 31110 61511 655
Net income10 21017 7836 7127 5058 6009 662
P/E ratio22,511,925,924,621,418,6
EPS ( $ )4,137,292,803,443,954,56
Dividend per Share ( $ )2,622,652,702,842,983,13
Yield2,82%3,06%3,72%3,36%3,52%3,70%
Reference price ( $ )92.8586.5972.6384.620884.620884.6208
Announcement Date01/27/2015
08:25am
01/27/2016
11:15am
01/25/2017
11:25am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt6 54916 48416 02517 81215 38912 452
Finance------
Operating income (EBITDA)19 36715 26014 31115 07415 91516 773
Leverage
(Debt/EBITDA)
0,34x1,08x1,12x1,18x0,97x0,74x
Capital Expenditure2 6242 3671 8622 0202 0742 127
Book Value Per Share (BVPS)27,7 $32,5 $31,5 $30,8 $31,5 $32,3 $
Cash Flow per Share5,63 $4,88 $4,78 $5,21 $5,69 $6,21 $
Announcement Date01/27/2015
08:25am
01/27/2016
11:15am
01/25/2017
11:25am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 221 731 M$ -
Entreprise Value (EV) 239 542 M$ 237 119 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 24,6x 21,4x
Capitalization / Revenue 4,51x 4,36x
EV / Revenue 4,87x 4,66x
EV / EBITDA 15,9x 14,9x
Yield (DPS / Price) 3,36% 3,52%
Price to book (Price / BVPS) 2,74x 2,69x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 24,3% 25,4%
operating Leverage (Delta EBIT / Delta Sales) - 2,37x
Net Margin (Net Profit / Revenue) 15,3% 16,9%
ROA (Net Profit / Asset) 7,01% 7,85%
ROE (Net Profit / Equities) 14,2% 15,6%
Rate of Dividend 82,5% 75,4%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,11% 4,08%
Cash Flow / Sales 24,7% 26,1%
Capital Intensity (Assets / Sales) 2,18x 2,15x
Financial Leverage (Net Debt / EBITDA) 1,18x 0,97x
EPS & Dividend